{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-023723","form_type":"8-K","ticker":"MD","cik":"0000893949","company_name":"Pediatrix Medical Group, Inc.","filed_at":"2025-02-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.714835+00:00","generated_at":"2026-05-26T10:00:29.984739+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Pediatrix Q4 net income $30M, Adjusted EPS $0.51, revenue up to $502M","bullets":["GAAP EPS $0.36 (vs $1.50 loss Q4 2023); Adjusted EPS $0.51 (vs $0.32).","Net revenue $502M, up from $496M; same-unit revenue grew 8.7%.","Adjusted EBITDA $68.7M (vs $50.8M); portfolio restructuring completed by Dec 31, 2024.","Preliminary 2025 Adjusted EBITDA guidance $215M-$235M.","Cash from operations $134.8M; total debt $616M; no revolver borrowings."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-023723","json":"https://secwatch.observer/filing/0000950170-25-023723.json","markdown":"https://secwatch.observer/filing/0000950170-25-023723.md","text":"https://secwatch.observer/filing/0000950170-25-023723.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/893949/000095017025023723/0000950170-25-023723-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/893949/000095017025023723/md-20250220.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T10:00:29.984739+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}